UNIVERSITY OF Helsinki (UH) – finland

helsingin yliopistoGeneral description:

The University of Helsinki is one of the best multidisciplinary research universities in the world. The high-quality research carried out by the university creates new knowledge for educating diverse specialists in various fields, and for utilisation in social decision-making and the business sector.

The university, with almost 4,000 researchers and teachers, operates on four campuses in Helsinki and at 17 other locations. There are 35,000 students, and a further 30,000 participate in adult education. Founded in 1640, the University of Helsinki wants to strengthen its position among the world’s leading multidisciplinary research universities and to actively promote the well-being of humanity and a fair society. The Institiute of Cinical medicine is the largest subject department of the Faculty of Medicine at the University of Helsinki. There are 130 staff on the payroll budget — 100 in research and education with about 30 in support services. In addition, there are 70 to 100 staff who work in research supported by outside funding. The Institute is comprised of 11 departments that cover all areas of clinical medicine.


UH has Research facilities fully equipped to perform isotope tracer studies, mixed meal tests and adipose tissue biopsies, laboratory premises for extensive lipid analyses and offices at Biomedicum Helsinki.


Prof Taskinen’s team is a member of Research Program Unit, Diabetes & Obesity Research program, University of Helsinki. Biomedicum Helsinki provides a unique set of both equipment and competence for clinical and basic research, excellent network and synergy benefits, as well as attractive training environment for scientists. HUCH imaging team provides services for MR spectroscopy. UH signed an agreement with Helsinki University Central Hospital (HUCH) which defines the cooperation modalities between the two organisations. This agreement specifies that the personnel HUCH can be provided as third party resources to UH. Such personnel provided by the third party will bring their expertise in WP6.


Other EU Projects:

Dr Taskinen is a member of SAB for Summit (EU –project: IMI JU – SUMMIT, IMI_Call_2008_1_08) and ISAC-CVON (International Scientific Advisory Committee of the CardioVasculair Onderzoek Nederlande), and has been a partner in EU Project: HEPADIP (Contract LSHM-CT-2005-018734).